Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
주식 순위
#2198
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical... Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
주가
$3.40
시가총액
$9.07B
변동 (1일)
-1.61%
변동 (1년)
-16.08%
국가
CN
거래 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
카테고리
Healthcare
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)의 발행 주식 수
October 2026 기준 발행 주식 수: 0
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 0입니다. October 2026 말 기준 회사는 0주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)의 발행 주식 수 기록 (2001 ~ 2026)
매년 말 기준 발행 주식 수
| 연도 | 발행 주식 수 | 변화 |
|---|---|---|
| 2025 | 2.65B | -0.64% |
| 2024 | 2.66B | -0.67% |
| 2023 | 2.68B | 2.83% |
| 2022 | 2.61B | 1.74% |
| 2021 | 2.56B | 0.00% |
| 2020 | 2.56B | 0.00% |
| 2019 | 2.56B | 1.60% |
| 2018 | 2.52B | 2.55% |
| 2017 | 2.46B | 6.08% |
| 2016 | 2.32B | 0.86% |
| 2015 | 2.30B | 0.11% |
| 2014 | 2.30B | 3.03% |
| 2013 | 2.23B | 14.02% |
| 2012 | 1.95B | 2.31% |
| 2011 | 1.91B | 1.77% |
| 2010 | 1.88B | 1.46% |
| 2009 | 1.85B | 0.00% |
| 2008 | 1.85B | 0.54% |
| 2007 | 1.84B | 8.49% |
| 2006 | 1.70B | -3.52% |
| 2005 | 1.76B | 0.00% |
| 2004 | 1.76B | 0.00% |
| 2003 | 1.76B | 0.00% |
| 2002 | 1.76B | 0.00% |
| 2001 | 1.76B | 0.00% |
유사 기업 또는 경쟁사의 발행 주식 수
| 회사 | 발행 주식 수 | 차이 | 국가 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | - |
IN
|
